(HealthDay News) -- Here are the latest clinical trials, courtesy of ClinicalConnection.com:
This study will evaluate the cardiovascular safety of an investigational drug combined with allopurinol in people with gout and cardiovascular problems. You must be 50 or older and have a uric acid level greater than 6.0 percent to qualify.
The research site is in San Antonio, Texas.
Please see http://www.clinicalconnection.com/clinical_trials/condition/gout.aspx.
Arthritis and Cardiovascular Disease
This study will compare celecoxib (Celebrex) to NSAIDs (Ibuprofen, Naproxen) in people with osteoarthritis or rheumatoid arthritis and risk factors for, or a history of, cardiovascular disease.
The research site is in Mesa, Ariz.
Please see http://www.clinicalconnection.com/clinical_trials/condition/arthritis.aspx.
Advanced Parkinson's Disease
This study will evaluate an investigational drug to treat certain side effects caused by levodopa (L-dopa) in people with advanced Parkinson's.
The research site is in Milwaukee, Wisc.
Please see http://www.clinicalconnection.com/clinical_trials/condition/parkinson's_disease.aspx.
Copyright 2011 ClinicalConnection.com. All rights reserved.
Copyright © 2011 HealthDay. All rights reserved.